Hubei Biocause Heilen Pharmaceutical Co., Ltd.
SZSE:301211.SZ
21.24 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 91.547 | 176.116 | 125.724 | 121.649 | 168.073 | 184.624 | 91.477 | 23.772 |
| Depreciation & Amortization
| 25.432 | 21.664 | 21.762 | 19.368 | 1.625 | 4.365 | 0.914 | 15.768 |
| Deferred Income Tax
| 0 | 0 | 1.662 | 0.675 | -0.097 | 1.412 | 0.974 | 0 |
| Stock Based Compensation
| 0 | 0 | -1.662 | -0.675 | 10.98 | -1.412 | 0 | 0 |
| Change In Working Capital
| -2.213 | -55.097 | 109.003 | -11.845 | -64.801 | 168.142 | -40.122 | -112.251 |
| Accounts Receivables
| 1.274 | 49.307 | 31.651 | -61.533 | 13.511 | 123.107 | -51.683 | -101.713 |
| Inventory
| 35.954 | -59.103 | -25.206 | 45.095 | -60.485 | 22.251 | -4.577 | -7.327 |
| Accounts Payables
| 0 | -46.287 | 100.896 | 3.919 | -17.73 | 21.373 | 15.164 | 0 |
| Other Working Capital
| -39.441 | 0.986 | 1.662 | 0.675 | -0.097 | 1.412 | -35.545 | -104.924 |
| Other Non Cash Items
| -18.693 | -5.62 | -5.695 | -5.188 | 16.775 | 15.194 | 23.912 | 7.274 |
| Operating Cash Flow
| 96.073 | 137.063 | 250.795 | 123.984 | 121.672 | 372.325 | 76.181 | -65.438 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -164.43 | -186.532 | -75.951 | -21.066 | -13.387 | -32.341 | -25.075 | -13.122 |
| Acquisitions Net
| 0 | 0 | 0.063 | 0.009 | 13.446 | 32.341 | 20.886 | 13.122 |
| Purchases Of Investments
| -1,044.346 | -21.403 | -103.976 | -480 | -771.914 | -339.086 | -110 | -46.8 |
| Sales Maturities Of Investments
| 99.219 | 0 | -0.063 | 730.704 | 829.593 | 115.401 | 45.175 | 46.944 |
| Other Investing Activites
| 0.095 | 0.466 | 0.063 | -0 | -13.387 | -32.341 | 0.144 | 0 |
| Investing Cash Flow
| -1,109.462 | -207.469 | -179.865 | 229.647 | 44.351 | -256.026 | -68.87 | -12.978 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | -1.334 | 0 | -20 | -97 | 15 | 52 |
| Common Stock Issued
| 0 | 0 | -4.057 | -11.021 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -138.24 | -96 | -72 | 0 | -2.282 | -3.92 | -6.451 | -2.771 |
| Other Financing Activities
| -1.631 | -1.168 | -4.057 | 1,416.16 | -101.086 | -7.914 | -0 | 0 |
| Financing Cash Flow
| -139.871 | -97.168 | -77.39 | 1,405.139 | -123.369 | -108.833 | 8.549 | 49.229 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 2.073 | 3.81 | 4.935 | -4.421 | -2.76 | 1.15 | -0.012 | -1.226 |
| Net Change In Cash
| -1,151.187 | -163.762 | -1.526 | 1,754.349 | 39.895 | 8.615 | 15.848 | -30.413 |
| Cash At End Of Period
| 543.04 | 1,694.227 | 1,857.989 | 1,859.515 | 105.165 | 65.271 | 56.655 | 40.808 |